Evidence map›Paper›PMID 38255895›Full record

ReviewInternational journal of molecular sciences2024

Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities.

Michelle Yi, Leslie Cruz Cisneros, Eric J Cho, Michael Alexander, Francesca A Kimelman, Lourdes Swentek, Antoney Ferrey, Ekamol Tantisattamo, Hirohito Ichii

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michelle YiDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.ORCID 0009-0007-7278-2661
Leslie Cruz CisnerosDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.
Eric J ChoDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.
Michael AlexanderDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.
Francesca A KimelmanDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.
Lourdes SwentekDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.
Antoney FerreyDepartment of Medicine, University of California Irvine, Irvine, CA 92697, USA.
Ekamol TantisattamoDepartment of Medicine, University of California Irvine, Irvine, CA 92697, USA.ORCID 0000-0003-0883-6892
Hirohito IchiiDepartment of Surgery, University of California Irvine, Irvine, CA 92697, USA.
University of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a chronic disease that induces many comorbidities, including cardiovascular disease, nephropathy, and liver damage. Many mechanisms have been suggested as to how diabetes leads to these comorbidities, of which increased oxidative stress in diabetic patients has been strongly implicated. Limited knowledge of antioxidative antidiabetic drugs and substances that can address diabetic comorbidities through the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway calls for detailed investigation. This review will describe how diabetes increases oxidative stress, the general impact of that oxidative stress, and how oxidative stress primarily contributes to diabetic comorbidities. It will also address how treatments for diabetes, especially focusing on their effects on the Nrf2 antioxidative pathway, have been shown to similarly affect the Nrf2 pathway of the heart, kidney, and liver systems. This review demonstrates that the Nrf2 pathway is a common pathogenic component of diabetes and its associated comorbidities, potentially identifying this pathway as a target to guide future treatments.

Indexed as

Diabetes MellitusNF-E2-Related Factor 2AntioxidantsComorbidityHumansHypoglycemic AgentsOxidative StressAntioxidantsHypoglycemic AgentsNF-E2-Related Factor 2diabetesheartkidneyliverNrf2oxidative stress

Identifiers

PMID38255895
PMCPMC10815857
OpenAlexW4390728304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.